CN105029627A - 一种青年男性用减肥饮料 - Google Patents
一种青年男性用减肥饮料 Download PDFInfo
- Publication number
- CN105029627A CN105029627A CN201510578976.1A CN201510578976A CN105029627A CN 105029627 A CN105029627 A CN 105029627A CN 201510578976 A CN201510578976 A CN 201510578976A CN 105029627 A CN105029627 A CN 105029627A
- Authority
- CN
- China
- Prior art keywords
- weight
- parts
- fruit
- raw material
- reducing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 30
- 239000002994 raw material Substances 0.000 claims abstract description 25
- 240000002853 Nelumbo nucifera Species 0.000 claims abstract description 18
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims abstract description 18
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims abstract description 18
- 235000012907 honey Nutrition 0.000 claims abstract description 18
- 244000241872 Lycium chinense Species 0.000 claims abstract description 16
- 235000015468 Lycium chinense Nutrition 0.000 claims abstract description 16
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims abstract description 14
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims abstract description 14
- 235000009685 Crataegus X maligna Nutrition 0.000 claims abstract description 14
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims abstract description 14
- 235000009486 Crataegus bullatus Nutrition 0.000 claims abstract description 14
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 14
- 235000009682 Crataegus limnophila Nutrition 0.000 claims abstract description 14
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 14
- 235000002313 Crataegus paludosa Nutrition 0.000 claims abstract description 14
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims abstract description 14
- 241000830535 Ligustrum lucidum Species 0.000 claims abstract description 14
- 240000000171 Crataegus monogyna Species 0.000 claims abstract 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 20
- 235000002837 Acetobacter xylinum Nutrition 0.000 claims description 18
- 239000009636 Huang Qi Substances 0.000 claims description 14
- 235000002722 Dioscorea batatas Nutrition 0.000 claims description 13
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims description 13
- 240000001811 Dioscorea oppositifolia Species 0.000 claims description 13
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims description 13
- 238000009835 boiling Methods 0.000 claims description 11
- 241000894006 Bacteria Species 0.000 claims description 10
- 244000235858 Acetobacter xylinum Species 0.000 claims description 9
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 9
- 238000010298 pulverizing process Methods 0.000 claims description 7
- 238000003756 stirring Methods 0.000 claims description 7
- 238000000855 fermentation Methods 0.000 claims description 6
- 230000004151 fermentation Effects 0.000 claims description 6
- 235000013305 food Nutrition 0.000 claims description 5
- 239000000706 filtrate Substances 0.000 claims description 3
- 239000012467 final product Substances 0.000 claims description 3
- 238000002386 leaching Methods 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 26
- 239000008280 blood Substances 0.000 abstract description 19
- 210000004369 blood Anatomy 0.000 abstract description 18
- 210000003734 kidney Anatomy 0.000 abstract description 16
- 210000004072 lung Anatomy 0.000 abstract description 12
- 210000000952 spleen Anatomy 0.000 abstract description 12
- 235000005911 diet Nutrition 0.000 abstract description 11
- 230000037213 diet Effects 0.000 abstract description 11
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract description 10
- 235000009508 confectionery Nutrition 0.000 abstract description 10
- 210000002784 stomach Anatomy 0.000 abstract description 8
- 230000008901 benefit Effects 0.000 abstract description 7
- 235000019640 taste Nutrition 0.000 abstract description 7
- 239000003053 toxin Substances 0.000 abstract description 7
- 231100000765 toxin Toxicity 0.000 abstract description 7
- 238000004519 manufacturing process Methods 0.000 abstract description 6
- 210000001124 body fluid Anatomy 0.000 abstract description 5
- 239000010839 body fluid Substances 0.000 abstract description 5
- 230000011132 hemopoiesis Effects 0.000 abstract description 5
- 235000012000 cholesterol Nutrition 0.000 abstract description 4
- 239000004519 grease Substances 0.000 abstract description 4
- 230000036541 health Effects 0.000 abstract description 4
- 150000002632 lipids Chemical class 0.000 abstract description 4
- 239000000203 mixture Substances 0.000 abstract description 3
- 238000002360 preparation method Methods 0.000 abstract description 3
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract description 2
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract description 2
- 108700012359 toxins Proteins 0.000 abstract 2
- 241001061264 Astragalus Species 0.000 abstract 1
- 235000010110 Astragalus glycyphyllos Nutrition 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 230000003467 diminishing effect Effects 0.000 abstract 1
- 235000004879 dioscorea Nutrition 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 239000013585 weight reducing agent Substances 0.000 abstract 1
- 230000006870 function Effects 0.000 description 12
- 241001092040 Crataegus Species 0.000 description 10
- 208000008589 Obesity Diseases 0.000 description 10
- 230000007812 deficiency Effects 0.000 description 10
- 235000020824 obesity Nutrition 0.000 description 10
- 239000003814 drug Substances 0.000 description 6
- 210000004185 liver Anatomy 0.000 description 6
- 230000009467 reduction Effects 0.000 description 6
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 238000000034 method Methods 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 208000031971 Yin Deficiency Diseases 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 230000003712 anti-aging effect Effects 0.000 description 3
- 230000035568 catharsis Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- 230000002107 myocardial effect Effects 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- 206010049865 Achromotrichia acquired Diseases 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 229920002527 Glycogen Polymers 0.000 description 2
- 201000005569 Gout Diseases 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 201000001431 Hyperuricemia Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- YXVXMURDCBMPRH-UHFFFAOYSA-N Lirinidine Natural products C1C2=CC=CC=C2C2=C(O)C(OC)=CC3=C2C1N(C)CC3 YXVXMURDCBMPRH-UHFFFAOYSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- ORJVQPIHKOARKV-UHFFFAOYSA-N Nuciferine Natural products C1C2=CC=CC=C2C2=C(OC)C(OC)=CC3=C2C1N(C)CC3 ORJVQPIHKOARKV-UHFFFAOYSA-N 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 210000000577 adipose tissue Anatomy 0.000 description 2
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 2
- 229930013930 alkaloid Natural products 0.000 description 2
- 150000003797 alkaloid derivatives Chemical class 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 230000002929 anti-fatigue Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 239000000496 cardiotonic agent Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 210000004351 coronary vessel Anatomy 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 229940096919 glycogen Drugs 0.000 description 2
- 230000007407 health benefit Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 230000002218 hypoglycaemic effect Effects 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000002045 lasting effect Effects 0.000 description 2
- 210000005229 liver cell Anatomy 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- ORJVQPIHKOARKV-OAHLLOKOSA-N nuciferine Chemical compound C1C2=CC=CC=C2C2=C(OC)C(OC)=CC3=C2[C@@H]1N(C)CC3 ORJVQPIHKOARKV-OAHLLOKOSA-N 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000007920 subcutaneous administration Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 1
- 208000021959 Abnormal metabolism Diseases 0.000 description 1
- 206010001580 Albuminuria Diseases 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- 208000031872 Body Remains Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 240000001879 Digitalis lutea Species 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 206010016952 Food poisoning Diseases 0.000 description 1
- 208000019331 Foodborne disease Diseases 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 235000017443 Hedysarum boreale Nutrition 0.000 description 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 description 1
- 241000590002 Helicobacter pylori Species 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- 229930194248 Licoflavone Natural products 0.000 description 1
- MEHHCBRCXIDGKZ-UHFFFAOYSA-N Licoflavone C Natural products CC(C)=CCC1=C(O)C=C(O)C(C(C=2)=O)=C1OC=2C1=CC=C(O)C=C1 MEHHCBRCXIDGKZ-UHFFFAOYSA-N 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- WSMYVTOQOOLQHP-UHFFFAOYSA-N Malondialdehyde Chemical compound O=CCC=O WSMYVTOQOOLQHP-UHFFFAOYSA-N 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 102000019197 Superoxide Dismutase Human genes 0.000 description 1
- 108010012715 Superoxide dismutase Proteins 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 206010047531 Visual acuity reduced Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003044 adaptive effect Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Chemical class CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 230000001458 anti-acid effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000000729 antidote Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 235000021407 appetite control Nutrition 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000003177 cardiotonic effect Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000032677 cell aging Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 210000003756 cervix mucus Anatomy 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 230000035487 diastolic blood pressure Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- IZEKFCXSFNUWAM-UHFFFAOYSA-N dipyridamole Chemical compound C=12N=C(N(CCO)CCO)N=C(N3CCCCC3)C2=NC(N(CCO)CCO)=NC=1N1CCCCC1 IZEKFCXSFNUWAM-UHFFFAOYSA-N 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 210000002468 fat body Anatomy 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000027119 gastric acid secretion Effects 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- 150000002357 guanidines Chemical class 0.000 description 1
- 229940037467 helicobacter pylori Drugs 0.000 description 1
- 210000003958 hematopoietic stem cell Anatomy 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 201000005630 leukorrhea Diseases 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 208000020442 loss of weight Diseases 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 229940118019 malondialdehyde Drugs 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000006371 metabolic abnormality Effects 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 108010071584 oxidized low density lipoprotein Proteins 0.000 description 1
- -1 oxygen radical Chemical class 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000001671 psychotherapy Methods 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000036186 satiety Effects 0.000 description 1
- 235000019627 satiety Nutrition 0.000 description 1
- 230000037384 skin absorption Effects 0.000 description 1
- 231100000274 skin absorption Toxicity 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 238000010583 slow cooling Methods 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- WNIFXKPDILJURQ-UHFFFAOYSA-N stearyl glycyrrhizinate Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=O)OCCCCCCCCCCCCCCCCCC)(C)CC5C4=CC(=O)C3C21C WNIFXKPDILJURQ-UHFFFAOYSA-N 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- 206010046901 vaginal discharge Diseases 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 230000004218 vascular function Effects 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 235000016804 zinc Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
- A23L2/382—Other non-alcoholic beverages fermented
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
本发明公开了一种青年男性用减肥饮料，原料由以下质量份：枸杞子15～20、山药12～15、黄芪10～12、黄精8～10、荷叶8～12、山楂10～15、女贞子5～8、甘草10～15、蜂蜜25～30组成；并公开了两种制备方法。本发明原料构成以补益排毒、延缓衰老，补气强心、调节血脂、降低血糖和胆固醇，促进造血，去厚腻、刮油脂，采用补消结合，日常饮用有益身体健康，健脾和胃，不影响饮食，排毒养颜、补肾润肺、生津益气，营养丰富、口感酸甜适中，适合青年男性的生理需求，在饮食健身的同时达到了减肥的功效。
Description
技术领域
本发明涉及一种饮料，尤其涉及一种青年男性用减肥饮料。
背景技术
减肥是以减少人体过度的脂肪、体重为目的的行为方式。指运用药物、饮食、运动、中医经络，心理疗法来达到减少身体脂肪堆积的一种现象，所有减肥方法均是直接或间接围绕热量为中心，有效指标为减少热量，健康指标为保护基础代谢，持续指标为食欲控制中的饱腹感和满足感。
目前的医学观点，肥胖算不上是疾病，却是许多人共同的烦恼。市面上有许多减肥的方法，比如，运动减肥，但却不是对每一个人都有效。有些人成功的减去了肥肉，不久精神松懈下来，人又胖了回去。
医学研究上同时认为，当人体内部缺少一种名为绿轻素的物质时，会导致人体血糖、脂肪及能量的调节紊乱，继而诱发并导致肥胖；当人体内的绿轻素浓度保持在正常水平时，人的体重便恢复正常。
从这些现象看来，显然现代医学对肥胖的病理研究还没有真正理清楚。现代医学对肥胖的理解是人体营养过剩时，身体会把多余的脂肪贮存在皮下，于是就造成了肥胖，也就是肥胖所增加的物质是脂肪，是一种被储存的能量。
现阶段，青年男性的肥胖人数越来越多，严重的影响了身体健康，现有的减肥方式主要是节食或加强锻炼，但是效果并不理想，节食容易造成营养不良和身体伤害，特别是针对肥胖的人，突然进行节食，伤害明显；而锻炼减肥对于肥胖的人是一件极其痛苦的事情，并且极易反弹。
发明内容
本发明的目的在于克服现有技术中的不足，提供一种饮用口感好，不影响日常饮食，具有强筋健体，补肾润肺、生津益气的青年男性用减肥饮料。
为达到上述目的，本发明所采用的技术手段是：一种青年男性用减肥饮料，原料由以下质量份：枸杞子15～20、山药12～15、黄芪10～12、黄精8～10、荷叶8～12、山楂10～15、女贞子5～8、甘草10～15、蜂蜜25～30组成。
进一步的，所述原料中枸杞子、山药、黄芪、黄精、荷叶、山楂、女贞子、甘草置于烘箱中，设定温度65～75℃烘干，取出置于食品粉碎机中粉碎，得到粉碎原料备用。
更进一步的，取粉碎原料放入承装有烧开后自然冷却至92～95℃的开水的容器中，焖至水温自然降温至42～50℃，加入蜂蜜，搅拌均匀，即刻饮用。
更进一步的，所述粉碎原料在放入容器中时加入茶叶。
进一步的，所述原料中枸杞子、山药、黄芪、黄精、荷叶、山楂、女贞子、甘草加水，煮制沸腾后自然冷却至35～38℃，加入蜂蜜，搅拌均匀后，加入拜耳结合酵母菌和木醋杆菌，保持温度28～32℃密闭发酵3～5d，发酵结束后，过滤取滤液即得。
更进一步的，所述加水的质量份100～120，加入拜耳结合酵母菌和木醋杆菌的质量份为0.02～0.04。
更进一步的，所述拜耳结合酵母菌和木醋杆菌按照1:1的质量份组合。
本发明的有益效果在于：原料构成以补益排毒、补肾润肺、补气强心、调节血脂、降低血糖和胆固醇，促进造血，去厚腻、刮油脂，采用补消结合，提高活力，日常饮用有益身体健康，健脾和胃，不影响饮食，补肾润肺、生津益气，口感酸甜适中，适合年轻男性的生理需求，在饮食健身的同时达到了减肥的功效。
具体实施方式
下面结合实施例对本发明做进一步的陈述。
实施例1
一种青年男性用减肥饮料，原料由以下质量份：枸杞子18、山药14、黄芪11、黄精9、荷叶10、山楂13、女贞子6、甘草14、蜂蜜28组成。
所述原料中枸杞子、山药、黄芪、黄精、荷叶、山楂、女贞子、甘草置于烘箱中，设定温度65～75℃烘干，取出置于食品粉碎机中粉碎，得到粉碎原料备用。
取粉碎原料放入承装有烧开后自然冷却至92～95℃的开水的容器中，焖至水温自然降温至42～50℃，加入蜂蜜，搅拌均匀，即刻饮用。
我们可以根据自己的喜好，将粉碎原料用纱布装袋，制成袋泡茶类的样式，多次采用上述方式冲泡。
操作时，我们可以将水烧开后，在烧水的水壶中自然冷却3分钟左右，水温自然冷却到92～95℃，将开水倒入茶壶或水杯中，将粉碎原料放入，盖上盖子使其缓慢冷却，自然降温至42～50℃，加入蜂蜜，搅拌均匀，即刻饮用。饮用的最佳水温是40度左右，当温度低于37度时，药效会下降。
饮用口感酸甜甘香而略有中涩。可将茶叶依据个人口味在开水倒入茶壶或水杯中时放入，口感更佳，对减肥效果更好，但因为有许多人不喝茶叶，因此未在原料中加入茶叶。
实施例2
一种青年男性用减肥饮料，原料由以下质量份：枸杞子18、山药13、黄芪11、黄精9、荷叶11、山楂13、女贞子7、甘草13、蜂蜜30组成。
所述原料中枸杞子、山药、黄芪、黄精、荷叶、山楂、女贞子、甘草加水，煮制沸腾后自然冷却至35～38℃，加入蜂蜜，搅拌均匀后，加入拜耳结合酵母菌和木醋杆菌，保持温度28～32℃密闭发酵3～5d，发酵结束后，过滤取滤液即得。
所述加水的质量份100～120，加入拜耳结合酵母菌和木醋杆菌的质量份为0.02～0.04。所述拜耳结合酵母菌和木醋杆菌按照1:1的质量份组合。
在本实施例中，蜂蜜即是有效成分，起到调节血液、通便排毒的功能，又作为发酵能量。
实施例3
与实施例1或2不同之处在于：原料由以下质量份：枸杞子15、山药12、黄芪10、黄精8、荷叶8、山楂10、女贞子5、甘草10、蜂蜜25组成。其制备方法采用实施例1或2的方法均可。
实施例4
与实施例1或2不同之处在于：原料由以下质量份：枸杞子20、山药15、黄芪12、黄精10、荷叶12、山楂15、女贞子8、甘草15、蜂蜜30组成。其制备方法采用实施例1或2的方法均可。
枸杞子：扶正固本和扶正怯邪，不但增强机体功能，促进健康恢复，而且能提高机体的抗病能力，抵御病邪的侵害。增强机体对各种有害刺激的适应能力。对癌细胞的生成和扩散有明显的抑制作用，治疗肝血不足、肾阴亏虚引起的视物昏花和夜盲症，能显著增加肌糖原、肝糖原的贮备量，提高人体活力，有抗疲劳的作用。改善大脑的功能，增强人的学习记忆能力。提高人体的适应性防御功能，使人遇到伤害性刺激时，如遇到缺氧、寒冷、失血等的忍耐承受能力。促进造血细胞增殖的作用，可以使白细胞数增多，增强人体的造血功能。有效地延缓衰老。提高皮肤吸收氧分的能力，起到美白作用。显著降低血清胆固醇和三酰甘油的含量，减轻和防止动脉硬化，治疗高血压。对过敏引起的胃肠道、关节疼出血等症状有缓解作用，这些作用是通过调节内分泌实现的。具有保肝补肾的作用，能抑制脂肪在肝细胞内沉积，并促进肝细胞的新生。枸杞子含有胍的衍生物，可以降低血糖，可以减轻体重，治疗肥胖症。枸杞子的有效成分枸橼酸甜菜碱具有治疗慢性肝炎、肝硬化等肝脏疾病的作用，有很好的疗效。
山药：味甘，性平；归肺、脾、肾经。补脾；养肺；固肾；益精。主脾虚泄泻；食少浮肿；肺虚咳喘；消渴；遗精；带下；肾虚尿频；外用治痈肿；瘰疬。有利于脾胃消化吸收功能，不论脾阳亏或胃阴虚，皆可食用。强健机体，滋肾益精的作用。大凡肾亏遗精、妇女白带多、小便频数等症，皆可服之。有降低血糖的作用。有效阻止血脂在血管壁的沉淀，预防心血疾病。取得益志安神，延年益寿的功效。
黄芪：性甘温，归肺经，有补气升阳、益卫固表之功能。有增强机体免疫功能、保肝、利尿、抗衰老、抗应激、降压和较广泛的抗菌作用。能消除实验性肾炎蛋白尿，增强心肌收缩力，调节血糖含量。黄芪不仅能扩张冠状动脉，改善心肌供血，提高免疫功能，而且能够延缓细胞衰老的进程。
黄精：味甘，性平，滋肾润肺，补脾益气。含天门冬氨酸、毛地黄糖甙、蒽醌类化合物、粘液质、糖类、烟酸、锌、铜、铁。有抗缺氧、抗疲劳、抗衰老作用；能增强免疫功能，增强新陈代谢；有降血糖和强心作用。用于阴虚肺燥，干咳痰少；消渴多饮；脾胃虚弱，脾气虚或脾阴不足；肾虚精亏，腰膝酸软，须发早白。对伤寒杆菌、金黄色葡萄球菌、抗酸杆菌有抑制作用。对肾上腺素引起的血糖过高呈显著抑制作用；抗病毒。
荷叶：味苦辛微涩、性凉，归心、肝、脾经；清香升散；具有消暑利湿，健脾升阳，散瘀止血的功效；荷叶碱是荷叶中提取的生物碱，荷叶碱可扩张血管，清热解暑，有降血压的作用。荷叶是“药食两用”的食物，荷叶中富含的黄酮类物质，是大多数氧自由基的清除剂，可以提高SOD（超氧化物歧化酶）的活力，减少MDA（脂质过氧化物丙二醛）及0X－LDL（氧化低密度脂蛋白）的生成，它可以增加冠脉流量，对实验性心肌梗塞有对抗作用；对急性心肌缺血有保护作用；对治疗冠心病、高血压等有显著效果；对降低舒张压，防治心律失常、心血管病等也起重要作用。荷叶中的生物碱有降血脂作用，服用后在人体肠壁上形成一层脂肪隔离膜，有效阻止脂肪的吸收，从根本上减重，并更有效的控制反弹。
山楂：含有维生素C、胡萝卜素等物质能阻断并减少自由基的生成，能增强机体的免疫力，有防衰老、抗癌的作用；能消除体内脂肪、减少脂肪吸收，美颜瘦身。具有降压，降脂，抗氧化，增强免疫力，清除胃肠道有害细菌等，还可预防肝癌。能显著降低血清胆固醇及甘油三酯，有效防治动脉粥样硬化；还能通过增强心肌收缩力、增加心输出量、扩张冠状动脉血管、增加冠脉血流量、降低心肌耗氧量等起到强心和预防心绞痛的作用。此外，有扩张血管和持久降压的作用。具有活血化淤的作用，是血淤型痛经患者的食疗佳品。
女贞子：味甘、苦，性凉；归肝，肾经；功效：补肝肾阴，乌须明目，抑制幽门螺杆菌，可以治疗胃病，还具有抑制嘌呤异常代谢用于痛风和高尿酸血症。主治：用于肝肾阴虚，腰酸耳鸣，须发早白；眼目昏暗，视物昏暗；阴虚发热，胃病及痛风和和高尿酸血症。
甘草：性平，味甘，归十二经；有解毒、祛痰、止痛、解痉以至抗癌等药理作用。补脾益气，滋咳润肺，缓急解毒，调和百药。生用主治咽喉肿痛，痛疽疮疡，胃肠道溃疡以及解药毒、食物中毒等；蜜炙主治脾胃功能减退，大便溏薄，乏力发热以及咳嗽、心悸等。对组胺引起的胃酸分泌过多有抑制作用；并有抗酸和缓解胃肠平滑肌痉挛作用。甘草黄酮、甘草浸膏及甘草次酸均有明显的镇咳作用；祛痰作用也较显著。还有抗炎，抗过敏作用，能保护发炎的咽喉和气管粘膜。甘草里含有甘草素，是一种类似激素的化合物，它有助于平衡体内的激素含量。甘草所含的次酸能阻断致癌物诱发肿瘤生长的作用。
蜂蜜：能改善血液的成分，促进心脑和血管功能，对肝脏有保护作用，能促使肝细胞再生，对脂肪肝的形成有一定的抑制作用。食用蜂蜜能迅速补充体力，消除疲劳，增强对疾病的抵抗力。还有杀菌的作用，不仅对牙齿无妨碍，还能在口腔内起到杀菌消毒的作用，能治疗中度的皮肤伤害，特别是烫伤，对胃肠功能有调节作用，可使胃酸分泌正常，增强肠蠕动的作用，可显著缩短排便时间。
对于肥胖的理解，发明人发现，形成肥胖的人会有气短、懒动等症状表现，在年轻男性身上体现出的是活力不强，嗜睡，因此，发明人创造的使用了本发明的原料，对人体主导滋补、通便排毒、益气补血；以补益排毒、增强活力、调节血脂、降低血糖和胆固醇，促进造血，去厚腻、刮油脂为主，采用补消结合，日常饮用有益身体健康，健脾和胃，不影响饮食，排毒养颜、补肾润肺、生津益气，营养丰富、口感酸甜适中，适合青年男性的生理需求，在饮食健身的同时达到了减肥的功效。
发明人认为，减肥必须找到问题的根本，不能单纯的依靠泄或超强运动，而应该在滋补身体，调节身体系统功能平衡上入手，通便排毒、生津益气、补肾润肺，增强活力，调节血脂、降低血糖和胆固醇，促进造血，去厚腻、刮油脂，使肥胖人自身机能调整和消化，逐渐摆脱肥胖，身体强健有力，而不是变成消瘦的一个人，从一个极端走向另一个极端。
通过分析后发现，实施例1和实施例2均能达到所需效果，但是具体区别在于，实施例1操作简单，而实施例2操作时间长，发酵过程控制要求高。实施例2通过发酵后，成分会有所改变，有益菌群增加，但药性强弱也会有变化，依据现有技术分析没有发现不利的问题。因此，申请人认为，实施例1的方式更适合个人操作，而实施例2更适合工业化生产。
本发明所公开的实施例只是对本发明技术方案的解释，并不作为对本发明的限制，凡是本领域技术人员在本发明基础上无创造性的替换，均在本发明的保护范围内。
Claims (7)
1.一种青年男性用减肥饮料，其特征在于：原料由以下质量份：枸杞子15～20、山药12～15、黄芪10～12、黄精8～10、荷叶8～12、山楂10～15、女贞子5～8、甘草10～15、蜂蜜25～30组成。
2.根据权利要求1所述的青年男性用减肥饮料，其特征在于：所述原料中枸杞子、山药、黄芪、黄精、荷叶、山楂、女贞子、甘草置于烘箱中，设定温度65～75℃烘干，取出置于食品粉碎机中粉碎，得到粉碎原料备用。
3.根据权利要求2所述的青年男性用减肥饮料，其特征在于：取粉碎原料放入承装有烧开后自然冷却至92～95℃的开水的容器中，焖至水温自然降温至42～50℃，加入蜂蜜，搅拌均匀，即刻饮用。
4.根据权利要求3所述的青年男性用减肥饮料，其特征在于：所述粉碎原料在放入容器中时加入茶叶。
5.根据权利要求1所述的青年男性用减肥饮料，其特征在于：所述原料中枸杞子、山药、黄芪、黄精、荷叶、山楂、女贞子、甘草加水，煮制沸腾后自然冷却至35～38℃，加入蜂蜜，搅拌均匀后，加入拜耳结合酵母菌和木醋杆菌，保持温度28～32℃密闭发酵3～5d，发酵结束后，过滤取滤液即得。
6.根据权利要求5所述的青年男性用减肥饮料，其特征在于：所述加水的质量份100～120，加入拜耳结合酵母菌和木醋杆菌的质量份为0.02～0.04。
7.根据权利要求6所述的青年男性用减肥饮料，其特征在于：所述拜耳结合酵母菌和木醋杆菌按照1:1的质量份组合。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510578976.1A CN105029627A (zh) | 2015-09-14 | 2015-09-14 | 一种青年男性用减肥饮料 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510578976.1A CN105029627A (zh) | 2015-09-14 | 2015-09-14 | 一种青年男性用减肥饮料 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105029627A true CN105029627A (zh) | 2015-11-11 |
Family
ID=54437072
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510578976.1A Pending CN105029627A (zh) | 2015-09-14 | 2015-09-14 | 一种青年男性用减肥饮料 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105029627A (zh) |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1211424A (zh) * | 1997-09-15 | 1999-03-24 | 王靖奇 | 降脂减肥散的药 |
| CN1481736A (zh) * | 2003-08-25 | 2004-03-17 | 保健饮品 | |
| CN101698028A (zh) * | 2009-11-03 | 2010-04-28 | 苏庆文 | 一种降脂减肥组合物及其制备方法 |
| CN102948563A (zh) * | 2012-11-27 | 2013-03-06 | 蒙思瑾 | 中药减肥保健茶 |
| CN103549052A (zh) * | 2013-07-18 | 2014-02-05 | 芜湖乐锐思信息咨询有限公司 | 一种美颜减肥茶及其制备方法 |
-
2015
- 2015-09-14 CN CN201510578976.1A patent/CN105029627A/zh active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1211424A (zh) * | 1997-09-15 | 1999-03-24 | 王靖奇 | 降脂减肥散的药 |
| CN1481736A (zh) * | 2003-08-25 | 2004-03-17 | 保健饮品 | |
| CN101698028A (zh) * | 2009-11-03 | 2010-04-28 | 苏庆文 | 一种降脂减肥组合物及其制备方法 |
| CN102948563A (zh) * | 2012-11-27 | 2013-03-06 | 蒙思瑾 | 中药减肥保健茶 |
| CN103549052A (zh) * | 2013-07-18 | 2014-02-05 | 芜湖乐锐思信息咨询有限公司 | 一种美颜减肥茶及其制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103602551B (zh) | 一种有助于消食健胃复方中草药发酵保健酒及其生产方法 | |
| CN104286273A (zh) | 铁皮石斛的用途及其茶叶制品 | |
| CN107873915A (zh) | 一种枸杞姜枣茶及其制备方法 | |
| CN104286272A (zh) | 铁皮石斛花的用途及其茶叶制品 | |
| CN101745087A (zh) | 一种具有解酒防醉作用的组合物及其制备方法 | |
| CN102100275B (zh) | 一种决明子茶 | |
| CN105878812A (zh) | 以金花茶-石斛为原料的解酒饮料及其生产方法 | |
| CN105077501A (zh) | 一种青年女性用减肥饮料 | |
| CN106509209A (zh) | 一种蜂胶保健茶及其制备方法 | |
| CN110522790A (zh) | 一种兼具抗疲劳、提高免疫力和除湿气功效的中药组合物及其制备方法和应用 | |
| CN105494781A (zh) | 一种虎杖降糖降脂保健茶 | |
| CN105166262A (zh) | 一种滋补安神山药南瓜脯的加工方法 | |
| CN105454900A (zh) | 一种当归生姜羊肉汤的制备方法 | |
| CN105981853A (zh) | 一种营养功能丰富的温和的暖茶饮料配方 | |
| CN105077449A (zh) | 一种少年男性减肥饮料 | |
| CN108419869A (zh) | 一种清热排毒下火的组合物、饮料及其制备方法 | |
| CN103656288A (zh) | 降血压的中药组合物及制备方法 | |
| CN106857937A (zh) | 一种具有辅助降血压功效的龙胆槐菊茶饮料 | |
| CN107047877A (zh) | 一种复方桑叶茶及其制备方法 | |
| CN105265971A (zh) | 一种中年男性用减肥饮料 | |
| CN106804810A (zh) | 一种八仙草清热解毒茶冻及其制备方法 | |
| CN112825938A (zh) | 一种红茶姜糖膏及其制备方法 | |
| CN105394279A (zh) | 一种添加中药的降脂减肥茶及其制备方法 | |
| CN108690775B (zh) | 养生保健白酒的生产方法与养生保健白酒及其用法 | |
| CN105029627A (zh) | 一种青年男性用减肥饮料 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20151111 |